Repetitive low-energy shock wave application without local anesthesia is more efficient than repetitive low-energy shock wave application with local anesthesia in the treatment of chronic plantar fasciitis

https://doi.org/10.1016/j.orthres.2004.09.003Get rights and content

Abstract

Background: It remains unclear whether application of local anesthesia (LA) interferes with clinical efficacy of extracorporeal shock wave therapy (ESWT) for chronic plantar fasciitis.

Aims: To evaluate the effect of local anesthesia on the clinical outcome after repetitive low-energy ESWT for chronic plantar fasciitis.

Methods: Eighty-six patients with chronic plantar fasciitis were randomly assigned to receive either low-energy ESWT without LA, given weekly for three weeks (Group I, n = 45; 3 × 2000 pulses, total energy flux density per shock 0.09 mJ/mm2) or identical ESWT with LA (Group II, n = 41). Primary outcome measure was: Reduction of pain from baseline to month 3 post-treatment in a pain numeric rating scale [0–10 points] during first steps in the morning, evaluated by an independent blinded observer. Calculations were based on intention-to-treat.

Results: No difference was found between the groups at baseline. At 3 months, the average pain score was 2.2 ± 2.0 points for patients of Group I, and 4.1 ± 1.5 points for patients of Group II. The mean between-group difference was 1.9 points (95% CI: [1.1–2.7 points]; P < .001). Significantly more patients of Group I achieved ⩾50% reduction of pain compared to Group II (67% vs 29%, P < .001).

Conclusion: ESWT as applied should be done without LA in patients suffering from chronic heel pain. LA applied prior treatment reduced the efficiency of low-energy ESWT.

Introduction

Plantar heel pain, commonly referred to as insertional plantar fasciitis, is a common condition among athletes as well as the general population. The characteristic complaints are knife-like pain at the calcaneal insertion of the medial part of the plantar fascia, typically worse on first arising in the morning, and often lasting months to years. Many treatment regimens exist but effectiveness is variable [8], [52], [55], [63]. Multiple publications focused on the evaluation of a clinically relevant effect of shock wave application on plantar heel pain, either of high-energy extracorporeal shock wave treatment (ESWT), applied in a single session with local or regional anesthesia [3], [6], [9], [28], [35], [36], [38], [59] or of low-energy ESWT, applied repetitively without local anesthesia [1], [4], [7], [11], [20], [21], [22], [23], [27], [44], [45], [46], [48], [51].

A shock wave is defined as an acoustic wave at the front of which pressure rises from the ambient value to its maximum within a few nanoseconds. Typical characteristics are a high peak-pressure amplitude with a rise time of nanosecond duration, a short lifecycle of microsecond duration, and a frequency spectrum ranging from the audible to the far ultrasonic level. A recently published multicenter trial [16] failed to show effectiveness of repetitive low-energy ESWT compared to placebo ESWT in patients with a recalcitrant plantar fasciitis. In this trial a local anesthesia was used to secure blinding of the patients. However, other authors pointed at flaws in the study design such as use of simultaneous local anesthesia [4], [12], [34], [47]. In an Austrian pilot study [4], 6 weeks after repetitive low-energy ESWT without local anesthesia 60% of cases achieved ⩾50% reduction of pain compared to 29% when identical ESWT was applied under local anesthesia.

This preliminary report provided new important aspects in the use of local anesthesia which needed to be confirmed in a prospective randomized controlled trial.

Section snippets

Patients and methods

The objective of the study was to evaluate the influence of local anesthesia (LA) on the efficiency of repetitive low-energy ESWT for patients with a chronic plantar fasciitis. The study was designed as a randomized, single-center, parallel treatment study with a blinded independent observer. The trial was approved by the hospital’s review board.

Primary outcome measure

The primary efficacy endpoint was defined as reduction of pain from baseline to month 3 post-treatment in the pain numeric rating scale (NRS) during first steps in the morning. The average pain score for patients who received ESWT without local anesthesia (Group I) was 6.9 ± 1.2 points at baseline, and 2.2 ± 2.0 points at 3 months. The average pain score for patients who received ESWT with local anesthesia (Group II) was 6.7 ± 1.1 points at baseline, and 4.1 ± 1.5 points at 3 months. The mean

Discussion

Recently repetitive low-energy extracorporeal shock wave treatment (ESWT) has been widely used to treat a number of musculoskeletal conditions, including insertional disorders such as plantar fasciitis.

In clinical practice, the application of a local anesthesia prior to low-energy ESWT became subject to criticism [4], [12], [47], therefore calling in question the negative results of a multicenter trial [16] on ESWT in patients suffering from chronic plantar fasciitis. In this trial local

Conclusions

We conclude that there is a positive treatment effect of repetitive low-energy ESWT as applied at 3-month follow-up in subjects with chronic plantar fasciitis. This positive treatment effect may be reduced by application of a local anesthetic to the painful area prior to low-energy ESWT. Until further experimental and clinical research has developed evidence for this effect, a local anesthetic should not be used for blinding in randomized-controlled trials evaluating the clinical efficacy of

Acknowledgement

No research or institutional support has been received for the conduction of this trial.

References (63)

  • P. Petrovic

    A PET activation study of dynamic mechanical allodynia in patients with mononeuropathy

    Pain

    (1999)
  • P. Petrovic et al.

    Imaging cognitive modulation of pain processing

    Pain

    (2002)
  • T.J. Shi

    Effect of peripheral nerve injury on dorsal root ganglion neurons in the C57 BL/6J mouse: marked changes both in cell numbers and neuropeptide expression

    Neuroscience

    (2001)
  • C.A. Speed

    Extracorporeal shock wave therapy for plantar fasciitis—a double blind randomised controlled trial

    J Orthop Res

    (2003)
  • N. Takahashi

    Application of shock waves to rat skin decreases calcitonin gene-related peptide immunoreactivity in dorsal root ganglion neurons

    Auton Neurosci

    (2003)
  • Y. Uchio

    Expression of neuropeptides and cytokines at the extensor carpi radialis brevis muscle origin

    J Shoulder Elbow Surg

    (2002)
  • C.J. Wang

    Shock wave therapy induces neovascularization at the tendon–bone junction. A study in rabbits

    J Orthop Res

    (2003)
  • T. Abt et al.

    Shock wave therapy for recalcitrant plantar fasciitis with heel spur: a prospective randomized placebo-controlled double-blind study

    Z Orthop Ihre Grenzgeb

    (2002)
  • R.G. Alvarez

    Symptom duration of plantar fasciitis and the effectiveness of orthotripsy

    Foot Ankle Int

    (2003)
  • Auersperg V et al. Influence of simultaneous local anesthesia on the outcome of repetitive low-energy shock wave...
  • A. Bickel

    Neuropeptide content of peripheral nerve in relation to nerve function in neuropathy

    Clin Neuropathol

    (1999)
  • M. Buch

    Extracorporeal shockwave therapy in symptomatic heel spurs

    Orthopäde

    (2002)
  • R. Buchbinder

    Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis

    JAMA

    (2002)
  • R. Buchbinder

    Plantar fasciitis

    N Engl J Med

    (2004)
  • H.S. Chen et al.

    Treatment of painful heel syndrome with shock waves

    Clin Orthop

    (2001)
  • R. Cosentino

    Efficacy of extracorporeal shock wave treatment in calcaneal enthesophytosis

    Ann Rheum Dis

    (2001)
  • Day B. Study design needs clinical input. Letter to the Editor, <http://www.ejbjs.org/cgi/eletters/84/11/1982>; 2002...
  • R.H. Gracely

    Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

    Arthritis Rheum

    (2002)
  • M. Haake

    Extracorporeal shock wave therapy for plantar fasciitis: randomised controlled multicentre trial

    BMJ

    (2003)
  • M. Haake et al.

    Unchanged c-Fos expression after extracorporeal shock wave therapy: an experimental investigation in rats

    Arch Orthop Trauma Surg

    (2002)
  • D.S. Hammer

    Extracorporal shock wave therapy in patients with tennis elbow and painful heel

    Arch Orthop Trauma Surg

    (2000)
  • Cited by (127)

    • Extracorporeal shock wave therapy for treating dyspareunia: A prospective, randomized, double-blind, placebo-controlled study

      2021, Annals of Physical and Rehabilitation Medicine
      Citation Excerpt :

      Several orthopedic and urological investigations reported no side effects of ESWT treatment [24,25]. The high tolerability of ESWT and the ability to apply shock waves without anesthesia permit evaluation without any risks to the patient [25]. Incidentally, anesthesia is not recommended before ESWT because of the significant killing of all positive outputs.

    • Influence of different energy patterns on efficacy of radial shock wave therapy

      2021, Journal of Orthopaedic Science
      Citation Excerpt :

      Secondly, we did not confirm the threshold of the efficacy of rESW application. However, the most followed clinical protocol for spasticity or musculoskeletal pain is <8000 pulses at a time [5,18,29,31–33]. Therefore, the application of several pulses with the lowest EFD cannot reduce CMAP amplitude.

    View all citing articles on Scopus
    View full text